LCN2 and neoplasm: A recent study using RNA sequencing and immunohistochemistry revealed an overexpression of C-type lectin domain family 3 member A (CLEC3A), matrix metallopeptidase 7 (MMP7) and lipocalin 2 (LCN2) in recurrent PanNETs compared to non-recurrent tumor [13].